Goldman Sachs’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $356M | Sell |
386,800
-185,000
| -32% | -$188M | 0.04% | 445 |
|
|
2025
Q4 | $615M | Sell |
571,800
-11,300
| -2% | -$10.8M | 0.08% | 244 |
|
|
2025
Q3 | $445M | Buy |
583,100
+381,700
| +190% | +$284M | 0.05% | 339 |
|
|
2025
Q2 | $157M | Buy |
201,400
+186,200
| +1,225% | +$145M | 0.02% | 654 |
|
|
2025
Q1 | $12.6M | Sell |
15,200
-12,600
| -45% | -$10.5M | ﹤0.01% | 2474 |
|
|
2024
Q4 | $21.5M | Sell |
27,800
-52,800
| -66% | -$43.7M | ﹤0.01% | 2064 |
|
|
2024
Q3 | $71.4M | Sell |
80,600
-29,700
| -27% | -$26.7M | 0.01% | 981 |
|
|
2024
Q2 | $99.9M | Buy |
110,300
+38,500
| +54% | +$30.8M | 0.02% | 798 |
|
|
2024
Q1 | $55.9M | Sell |
71,800
-98,000
| -58% | -$69.7M | 0.01% | 1090 |
|
|
2023
Q4 | $99M | Sell |
169,800
-32,600
| -16% | -$19M | 0.02% | 792 |
|
|
2023
Q3 | $109M | Buy |
202,400
+71,600
| +55% | +$36.9M | 0.02% | 678 |
|
|
2023
Q2 | $61.3M | Buy |
130,800
+74,800
| +134% | +$31.4M | 0.01% | 960 |
|
|
2023
Q1 | $19.2M | Sell |
56,000
-33,200
| -37% | -$11.2M | ﹤0.01% | 1849 |
|
|
2022
Q4 | $32.6M | Sell |
89,200
-29,200
| -25% | -$10.4M | 0.01% | 1525 |
|
|
2022
Q3 | $38.3M | Sell |
118,400
-28,000
| -19% | -$8.87M | 0.01% | 1309 |
|
|
2022
Q2 | $47.5M | Sell |
146,400
-14,500
| -9% | -$4.35M | 0.01% | 1157 |
|
|
2022
Q1 | $46.1M | Sell |
160,900
-17,800
| -10% | -$4.58M | 0.01% | 1342 |
|
|
2021
Q4 | $49.4M | Buy |
178,700
+128,300
| +255% | +$32.5M | 0.01% | 1354 |
|
|
2021
Q3 | $11.6M | Sell |
50,400
-7,000
| -12% | -$1.73M | ﹤0.01% | 2577 |
|
|
2021
Q2 | $13.2M | Sell |
57,400
-115,000
| -67% | -$23.1M | ﹤0.01% | 2435 |
|
|
2021
Q1 | $32.2M | Sell |
172,400
-108,800
| -39% | -$21.3M | 0.01% | 1526 |
|
|
2020
Q4 | $47.5M | Buy |
281,200
+175,400
| +166% | +$26.2M | 0.01% | 1164 |
|
|
2020
Q3 | $15.7M | Sell |
105,800
-36,000
| -25% | -$5.57M | ﹤0.01% | 1934 |
|
|
2020
Q2 | $23.3M | Buy |
141,800
+111,500
| +368% | +$17.1M | 0.01% | 1556 |
|
|
2020
Q1 | $4.2M | Buy |
30,300
+15,600
| +106% | +$2.14M | ﹤0.01% | 2775 |
|
|
2019
Q4 | $1.93M | Sell |
14,700
-58,900
| -80% | -$6.83M | ﹤0.01% | 3672 |
|
|
2019
Q3 | $8.23M | Buy |
73,600
+11,300
| +18% | +$1.26M | ﹤0.01% | 2474 |
|
|
2019
Q2 | $6.9M | Sell |
62,300
-699,100
| -92% | -$82.3M | ﹤0.01% | 2625 |
|
|
2019
Q1 | $98.8M | Buy |
761,400
+288,600
| +61% | +$35.1M | 0.03% | 672 |
|
|
2018
Q4 | $54.7M | Buy |
472,800
+397,700
| +530% | +$44.4M | 0.02% | 1025 |
|
|
2018
Q3 | $8.06M | Sell |
75,100
-123,500
| -62% | -$12.3M | ﹤0.01% | 2617 |
|
|
2018
Q2 | $16.9M | Sell |
198,600
-108,900
| -35% | -$8.94M | ﹤0.01% | 2018 |
|
|
2018
Q1 | $23.8M | Buy |
307,500
+66,900
| +28% | +$5.39M | 0.01% | 1714 |
|
|
2017
Q4 | $20.3M | Buy |
240,600
+12,400
| +5% | +$1.06M | ﹤0.01% | 1936 |
|
|
2017
Q3 | $19.5M | Sell |
228,200
-28,000
| -11% | -$2.3M | ﹤0.01% | 2007 |
|
|
2017
Q2 | $21.1M | Buy |
256,200
+63,600
| +33% | +$5.19M | 0.01% | 1886 |
|
|
2017
Q1 | $16.2M | Sell |
192,600
-447,500
| -70% | -$35.8M | ﹤0.01% | 2038 |
|
|
2016
Q4 | $47.1M | Sell |
640,100
-55,200
| -8% | -$4.11M | 0.01% | 1314 |
|
|
2016
Q3 | $55.8M | Buy |
695,300
+275,900
| +66% | +$22.1M | 0.02% | 1117 |
|
|
2016
Q2 | $33M | Sell |
419,400
-237,300
| -36% | -$17.9M | 0.01% | 1407 |
|
|
2016
Q1 | $47.3M | Buy |
656,700
+466,500
| +245% | +$35.3M | 0.02% | 1112 |
|
|
2015
Q4 | $16M | Sell |
190,200
-77,400
| -29% | -$6.42M | 0.01% | 1913 |
|
|
2015
Q3 | $22.4M | Buy |
267,600
+79,200
| +42% | +$6.69M | 0.01% | 1635 |
|
|
2015
Q2 | $15.7M | Sell |
188,400
-168,200
| -47% | -$12.8M | ﹤0.01% | 1981 |
|
|
2015
Q1 | $25.9M | Buy |
356,600
+54,100
| +18% | +$3.85M | 0.01% | 1567 |
|
|
2014
Q4 | $20.9M | Buy |
302,500
+32,400
| +12% | +$2.19M | 0.01% | 1792 |
|
|
2014
Q3 | $17.5M | Sell |
270,100
-29,200
| -10% | -$1.85M | 0.01% | 1894 |
|
|
2014
Q2 | $18.6M | Sell |
299,300
-126,600
| -30% | -$7.55M | 0.01% | 1848 |
|
|
2014
Q1 | $25.1M | Sell |
425,900
-253,600
| -37% | -$14.2M | 0.01% | 1579 |
|
|
2013
Q4 | $34.7M | Sell |
679,500
-43,100
| -6% | -$2.16M | 0.01% | 1331 |
|
|
2013
Q3 | $36.4M | Buy |
722,600
+272,900
| +61% | +$14.3M | 0.01% | 1186 |
|
|
2013
Q2 | $22.1M | Buy |
+449,700
| New | +$24.5M | 0.01% | 1472 |
|
Other funds holding LLY
VCM
VPM
Goldman Sachs's LLY Position: Q1 2026 in Review
Goldman Sachs increased its Eli Lilly (LLY) stake by 6.6% in Q1 2026, buying an estimated $396M and bringing the position to 6,340,865 shares worth $5.83B. The position accounts for 0.67% of the portfolio, ranked #15.
Goldman Sachs first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.39B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Goldman Sachs held 6,340,865 shares of Eli Lilly worth $5.83B as of Q1 2026.
- Goldman Sachs bought 390,971 Eli Lilly shares in Q1 2026, an estimated $396M.
- Eli Lilly made up 0.67% of Goldman Sachs's portfolio in Q1 2026, its #15 holding.
- Goldman Sachs first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Eli Lilly position peaked at $6.39B in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.